USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular's Paratope-PLUS™ CDR-Scanning [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
PHILADELPHIA April 21, 2026 /PRNewswire/ -- Integral Molecular, the industry leader in the discovery and engineering of antibodies against membrane proteins, announces that the United States Patent and Trademark Office (USPTO) has allowed a patent covering a genus of antibodies enabled using the company's Paratope-PLUS ® CDR-Scanning technology. The allowed claims protect a lead candidate and a family of structurally related antibodies binding the cancer target GPRC5D that share a common 'paratope' structural feature that is responsible for target binding. (PRNewsfoto/Integral Molecular Inc.) The issued patent demonstrates a new pathway for protecting antibody genera using structure-based claims supported by comprehensive experimental data, based on Integral Molecular's 2025 publication in Nature Biotechnology . The allowance comes in the wake of the 2023 U.S. Supreme Court ruling in Amgen Inc. v. Sanofi, which emphasized that genus claims must be supported by sufficient disclosu
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- What to Expect From Amgen's Next Quarterly Earnings Report [Yahoo! Finance]Yahoo! Finance
- Amgen (AMGN) was given a new $366.00 price target by Canaccord Genuity Group Inc..MarketBeat
- UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 [Yahoo! Finance]Yahoo! Finance
- ISPE Announces Keynote Speakers for its First-Ever 2026 ISPE AI in Life Sciences Summit - Powered by GAMP® [Yahoo! Finance]Yahoo! Finance
- ???????2035????589?????? ?????????????????????CAGR18.15%???? : ???????????????????? [CNET News]CNET News
AMGN
Earnings
- 2/3/26 - Beat
AMGN
Sec Filings
- 4/15/26 - Form DEFA14A
- 4/7/26 - Form DEFA14A
- 4/7/26 - Form DEF
- AMGN's page on the SEC website